Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer Screening: Implications for Diagnosis and Follow-Up Strategies
Objective: Cervical cancer is a major cause of cancer-related mortality, necessitating effective screening and diagnostic methods. This study aimed to assess the performance of cervicovaginal smear (CVS) and human papillomavirus (HPV)-DNA co-test. Study design: The pathology results of 225 female pa...
Main Authors: | Neslihan Kaya Terzi, Ozden Yulek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/14/6/611 |
Similar Items
-
The Effect of Age on Cervical Cancer Screening in Women Aged 20-29
by: Hasan Aykut Tuncer, et al.
Published: (2020-01-01) -
Cytology May not be Sufficient for Cervical Screening in Women with HPV Types Other than Type 16-type 18
by: Erhan Okuyan, et al.
Published: (2023-03-01) -
HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?
by: Vitor Caeiro, et al.
Published: (2023-01-01) -
Comparison of liquid based cytology results with conventional cytology results in screening cervical cancer
by: Nezaket Kadioglu, et al.
Published: (2016-12-01) -
Human Papillomavirus (HPV) test and Pap Smear in Screening for Cervical Cancer: A systematic review on systematic review study
by: Amir Nejati, et al.
Published: (2020-09-01)